ARTL

Conviction 8HealthcareScan · Thu, Sep 24, 2026

Artelo Biosciences, Inc. (ARTL) closed at $5.15 (-29.55%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 45, RS Rating 12, -95.1% from its 52-week high, -59.5% year to date. Sector: Healthcare · Pharmaceutical Preparations.

ARTL$5.15-29.55%

ResistanceSupportVol 14

Vol MA14 1.91M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

ARTELO BIOSCIENCES, INC.Pharmaceutical Preparationswww.artelobio.com ↗

Price5.15

Change-29.55%

Gap-33.11%

Rel volume0.37×

Avg volume1.39M

Avg $ vol9.91M

SMA 205.52

SMA 507.20

SMA 20020.61

Price vs 50-28.49%

Price vs 200-75.02%

MA stackbearish

50/200 cross—

Supertrendup · 4.62

RSI (14)45

MACD hist0.16

MACD crossbull · 1d

Stoch %K / %D14 / 22

ADX (14)48

+DI / −DI53 / 13

RSI divergence—

MACD divergence—

ATR %29.89%

ADR %20.00%

52w high105.40

52w low3.75

From 52w high-95.11%

Above 52w low+37.33%

New 52w highNo

SqueezeOff

Bollinger width75.49%

%B0.41

Donchian pos13.84%

Donchian high15.73

Donchian low3.45

AVWAP (52w high)34.16

vs AVWAP high-84.92%

AVWAP (52w low)8.75

vs AVWAP low-41.13%

OBV trendUp

Chaikin MF (20)-0.36

Today vs 20d0.37×

Avg vol (14d)1.91M

Avg vol (20d)1.39M

Avg $ vol (20d)9.91M

Market cap23.66M

RS Rating12 / 99

RS 3m (vs SPY)-60.09%

RS 6m (vs SPY)-106.20%

RS line new highNo

Trend template2/8

Technical rank10.1

1 week+29.72%

1 month-28.19%

3 months-55.60%

6 months-89.38%

1 year-91.07%

YTD-59.45%

P/E-1.84

P/B4.74

P/S—

P/FCF—

EPS-12.52

Div yield—

ROE-257.73%

ROA-199.40%

Debt/Eq—

Current3.00

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-31.07%

Price target—

Target upside—

Analyst rating—

Institutional2.47%

Ent. value13.39M

Revenue—

Net income-2.43M

Gross profit—

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out3.49M

Employees7

ListedTue, Oct 13, 2015

Free float764.39K

Float %81.5%

Short interest35.92K

Days to cover0.2d

Short volume46.9%

Squeeze score15 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction8 / 100

Pattern quality—

Tech rank10.1 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.20

Support3.66

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ARTL

All disclosures →

No recent disclosed trades by Congress in ARTL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ARTL

No recent insider (Form 4) filings in ARTL. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ARTL · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

ARTL

Recent news

Get daily signals & real-time alerts.